ADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
TUESDAY, June 27, 2023 -- Once-weekly tirzepatide provides substantial and clinically meaningful reductions in body weight in adults with obesity and type 2 diabetes, according to a study published online June 26 in the The Lancet to coincide with...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Obesity | Pharmaceuticals | Study | Weight Loss